Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
B
Details...
Enter Symbol
JAZZ (NASDAQ: JAZZ)
Sector: Medical
Current Price :
$63.75
52 Week Low
$41.23
52 Week High
$63.75
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
58M
Market Cap:
$3.19B
Avg Volume:
611872
P/E Ratio:
12.370
PEG Ratio:
0.400
1m
3m
6m
1y
2y
Opinion and Analysis
What The Market Wants: ISM Leads Market Down Bearish Path
Apr 02, 2013 01:19 PM |
APOL
,
JAZZ
,
SNTS
Jazz Pharmaceuticals (JAZZ) Retreats after FDA Denies Citizens Petition
Nov 14, 2012 10:53 AM |
JAZZ
Jazz Pharma (JAZZ) Initiated At 'Buy' By Brean Murray, $81 PT
Sep 27, 2012 11:13 AM |
CELG
,
JAZZ
More Articles on JAZZ..
Press Releases
Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events
May 13, 2013 09:43 PM |
JAZZ
JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2013 FINANCIAL RESULTS
May 07, 2013 05:52 PM |
JAZZ
Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders
Mar 05, 2013 09:05 AM |
JAZZ
More Press Releases on JAZZ..
SEC Filings
Form 4 Jazz Pharmaceuticals For: Mar 12 Filed by: COZADD BRUCE C (10K)
Mar 12, 2013 08:24 PM
Form 4 Jazz Pharmaceuticals For: Mar 08 Filed by: KRAVIS HENRY R (10K)
Mar 12, 2013 05:46 PM
Form 4 Jazz Pharmaceuticals For: Mar 08 Filed by: KKR Millennium Fund L.P. (10K)
Mar 12, 2013 05:43 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
JAZZ
Compare to S&P
YTD
3.36 %
-5.22 %
4 Weeks
-3.40 %
-3.30 %
12 Weeks
-4.03 %
-7.25 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
16.81 %
EPS Growth in Last Year:
44.79 %
Sales Growth in Last Quarter:
4.67 %
Sales Growth in Last Quarter:
119.91 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##